These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2424197)

  • 21. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D; Beam TR; John JF; Ribner B; Cantey R; Welsh CH; Ellison RT; Young EJ; Hamill RJ; Leaf H; Schein RM; Mulligan M; Johnson C; Abrutyn E; Griffiss JM; Slagle D
    J Infect Dis; 1996 Sep; 174(3):537-43. PubMed ID: 8769611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative characterization of dipentameric (IgM)(2) and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use.
    Tarköy M; Wyss M; Rudolf MP
    J Pharm Biomed Anal; 2010 Apr; 51(5):1084-90. PubMed ID: 20005064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M
    J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudomonas aeruginosa antibodies in human plasma.
    Doi T; Yoshioka M; Nakajima T
    Jpn J Exp Med; 1976 Jun; 46(3):149-54. PubMed ID: 60502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
    Preston MJ; Berk JM; Hazlett LD; Berk RS
    Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis].
    Kolker II; Stanislavskiĭ ES; Grishina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
    Holder IA; Naglich JG
    Am J Med; 1984 Mar; 76(3A):161-7. PubMed ID: 6424445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Lombardo D; Miner KM; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 Aug; 56(8):1873-9. PubMed ID: 3135264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
    Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.
    Sensakovic JW; Bartell PF
    Infect Immun; 1977 Nov; 18(2):304-9. PubMed ID: 411754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.